Characterization of Lactobacillus gasseri isolates from a breast-fed infant

Gut Microbes

Volumn 3, Issue 1, 2012, Pages

  da Cunha, Luciana Rodrigues ^a,b,c   Ferreira, Célia L L Fortes ^a   Durmaz, Evelyn ^b   Goh, Yong Jun ^b   Sanozky Dawes, Rosemary B ^b   Klaenhammer, Todd R ^b  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Adhesion; Antibiotic resistance; Human milk bank; Lactobacillus gasseri; Probiotic safety

Indexed keywords

MUCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BREAST MILK; CONTROLLED STUDY; HEMOLYSIS; HUMAN; LACTIC ACID BACTERIUM; LACTOBACILLUS GASSERI; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; PLASMID; STOMACH JUICE;

LACTOBACILLUS GASSERI;

EID: 84858595941     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Tuohy KM, Probert HM, Smejkal CW, Gibson GR. Using probiotics and prebiotics to improve gut health. Drug Discov Today 2003; 8:692-700; PMID:12927512; http://dx.doi.org/10.1016/S1359-6446(03)02746-6
2. Wall R, Fitzgerald G, Hussey S, Ryan T, Murphy B, Ross P, et al. Genomic diversity of cultivable Lactobacillus populations residing in the neonatal and adult gastrointestinal tract. FEMS Microbiol Ecol 2007; 59:127-37; PMID:16978242; http://dx.doi.org/10.1111/j.1574-6941.2006.00202.x
3. Kelly D, King T, Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 2007; 622:58-69; PMID: 17612575; http://dx.doi.org/10.1016/j.mrfmmm.2007.03.011
4. Food and Agriculture Organization of the United Nations and World Health Organization. Guidelines For The Evaluation Of Probiotics In Food And Agriculture Organization For The United Nations And World Health Organization Working Group Report, On Line 2002.
5. Schrezenmeier J, De Vrese M. Probiotics, Prebiotics and Symbiotic - approaching a definition. Am J Clin Nutr 2001; 73:361S-4S.
6. González-Martínez BE, Treviño MG, Jiménez-Salas Z. Bacteriocinas de probióticos. Revista de la Facultad de Salud Pública y Nutrición 2003; 4:n 2.
7. Collado MC, Jalonen L, Meriluoto J, Salminen S. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. Asia Pac J Clin Nutr 2006; 15:570-5; PMID: 17077078
8. Forsythe P, Bienenstock J. Immunomodulation by commensal and probiotic bacteria. Immunol Invest 2010; 39:429-48; PMID:20450286; http://dx.doi.org/10.3109/08820131003667978
9. Round JL, Mamanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-23; PMID:19343057; http://dx.doi.org/10.1038/nri2515
10. Griffin IJ, Davila PM, Abrams SA. Non-digestible oligosaccharides and calcium absorption in girls with adequates calcium intakes. Br J Nutr 2002; 87:187-91; PMID:11898772; http://dx.doi.org/10.1079/BJN/2002536
11. Commane D, Hughes R, Shortt C, Rowland I. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res 2005; 591:276-89; PMID:16095630; http://dx.doi.org/10.1016/j.mrfmmm.2005.02.027
12. Lin SY, Chen CT. Reduction of cholesterol by Lactobacillus acidophilus in culture broth. Journal Food Drug Anal 2000; 2000:97-102.
13. Young RJ, Huffman S. Probiotic use in children. J Pediatr Health Care 2003; 17:277-83; PMID: 14610440; http://dx.doi.org/10.1016/S0891-5245(03)00070-1
14. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr 2001; 73(Suppl):444S-50S; PMID:11157355
15. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-9; PMID:11297958; http://dx.doi.org/10.1016/S0140-6736(00)04259-8
16. Gill HS. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2003; 17:755-73; PMID:14507586; http://dx.doi.org/10.1016/S1521-6918(03)00074-X
17. Schanler RJ, Hurst NM, Lau C. The use of human milk and breast-feeding in premature infants. Clin Perinatol 1999; 26:379-98.
18. Giugliani ERJ. Rede Nacional de Bancos de Leite Humano do Brasil: tecnologia para exportar. J Pediatr (Rio J) 2002; 78:183-4; PMID:14647769; http://dx.doi.org/10.1590/S0021-75572002000300001
19. FIOCRUZ. Fundação Oswaldo Cruz. www.fiocruz.br//redeBLH/cgi/cgilua.exe/sys/start/htm?tpl=home&id=ce. Accessed December, 2010.
20. Bom dia Brasil: https://www.medplan.com.br/materias/2/7059.html. Accessed July, 2008.
21. Borba LM, Castro LCV, Fanceschine SCC, Ferreira CLLF. Composição do Leite Humano e Microbiota Predominantemente Bífida de Lactente em Aleitamento Materno Exclusivo. Nutrire 2003; 25:135-54.
22. Kullen MJ, Sanozky-Dawes RB, Crowell DC, Klaenhammer TR. Use of the DNA sequence of variable regions of the 16S rRNA gene for rapid and accurate identification of bacteria in the Lactobacillus acidophilus complex. J Appl Microbiol 2000; 89:511-6; PMID:11021584; http://dx.doi.org/10.1046/j.1365-2672.2000.01146.x
23. Tanskanen EI, Tulloch DL, Hillier AJ, Davidson BE. Pulsed-field gel electrophoresis of SmaI digests of lactococcal genomic DNA, a novel method of strain identification. Appl Environ Microbiol 1990; 56:3105-11; PMID:16348318
24. Eaton TJ, Gasson MJ. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Applied Environment Biology 2001; 67:1628-35; http://dx.doi.org/10.1128/AEM.67.4.1628-1635.2001
25. Harris LJ, Daescheyl MA, Stiles ME, Klaenhammer TR. Antimicrobial activity of lactic acid bacteria against Listeria monocytogenes. J Food Prot 1999; 52:384-87.
26. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45:493-6; PMID:5325707
27. Jones RN, Ballow CH, Biedenbach DJ, Deinhart JA, Schentag JJ. Antimicrobial activity of quinupristindalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. Diagn Microbiol Infect Dis 1998; 31:437-51; PMID:9635235; http://dx.doi.org/10.1016/S0732-8893(98)80002-3
28. O'Sullivan DJ, Klaenhammer TR. Rapid mini-prep isolation of high quality DNA from Lactococcus and Lactobacillus species. Appl Environ Microbiol 1993; 59:2730-3; PMID:16349028
29. Altermann E, Klaenhammer TR. GAMOLA: a new local solution for sequence annotation and analyzing draft and finished prokaryotic genomes. OMICS 2003; 7:161-9; PMID:14506845; http://dx.doi.org/10.1089/153623103322246557
30. Goh YJ, Klaenhammer TR. Functional roles of aggregation-promoting-like factor in stress tolerance and adherence of Lactobacillus acidophilus NCFM. Appl Environ Microbiol 2010; 76:5005-12; PMID: 20562289; http://dx.doi.org/10.1128/AEM.00030-10
31. Goh YJ, Azcárate-Peril MA, O'Flaherty S, Durmaz E, Valence F, Jardin J, et al. Development and application of a upp-based counterselective gene replacement system for the study of the S-layer protein SlpX of Lactobacillus acidophilus NCFM. Appl Environ Microbiol 2009; 75:3093-105; PMID:19304841; http://dx.doi.org/10.1128/AEM.02502-08
32. Kleeman EG, Klaenhammer TR. Adherence of Lactobacillus species to human fetal intestinal cells. J Dairy Sci 1982; 65:2063-9; PMID:7153393; http://dx.doi.org/10.3168/jds.S0022-0302(82)82462-4
33. Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol 2001; 2:43-53; PMID:11721280
34. Smith SI, Aweh AJ, Coker AO, Savage KO, Abosede DA, Oyedeji KS. Lactobacilli in human dental caries and saliva. Microbios 2001; 105:77-85; PMID: 11393751
35. Martín R, Soberón N, Vaneechoutte M, Flórez AB, Vázquez F, Suárez JE. Characterization of indigenous vaginal lactobacilli from healthy women as probiotic candidates. Int Microbiol 2008; 11:261-6; PMID: 19204898
36. Ryan KA, Jayaraman T, Daly P, Canchaya C, Curran S, Fang F, et al. Isolation of lactobacilli with probiotic properties from the human stomach. Lett Appl Microbiol 2008; 47:269-74; PMID:19241519; http://dx.doi.org/10.1111/j.1472-765X.2008.02416.x
37. Azcarate-Peril MA, Altermann E, Goh YJ, Tallon R, Sanozky-Dawes RB, Pfeiler EA, et al. Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl Environ Microbiol 2008; 74:4610-25; PMID:18539810; http://dx.doi.org/10.1128/AEM.00054-08
38. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 1999; 43:727-37; PMID:10103173
39. Hummel AS, Hertel C, Holzapfel WH, Franz CM. Antibiotic resistances of starter and probiotic strains of lactic acid bacteria. Appl Environ Microbiol 2007; 73:730-9; PMID:17122388; http://dx.doi.org/10.1128/AEM.02105-06
40. Danielsen M, Wind AA. Susceptibility of Lactobacillus spp. to antimicrobial agents. Int J Food Microbiol 2003; 82:1-11; PMID:12505455; http://dx.doi.org/10.1016/S0168-1605(02)00254-4
41. Charteris WP, Kelly PM, Morelli L, Collins JK. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol 1998; 84:759-68; PMID:9674129; http://dx.doi.org/10.1046/j.1365-2672.1998.00407.x
42. Charteris WP, Kelly PM, Morelli L, Collins JK. Gradient diffusion antibiotic susceptibility testing of potentially probiotic lactobacilli. J Food Prot 2001; 64:2007-14; PMID:11770631
43. Begley M, Gahan CGM, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005; 29:625-51; PMID:16102595; http://dx.doi.org/10.1016/j.femsre.2004.09.003
44. Elkins CA, Mullis LB. Bile-mediated aminoglycoside sensitivity in Lactobacillus species likely results from increased membrane permeability attributable to cholic acid. Appl Environ Microbiol 2004; 70:7200-9; PMID: 15574918; http://dx.doi.org/10.1128/AEM.70.12.7200-7209.2004
45. Levine C, Hiasa H, Marians KJ. DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim Biophys Acta 1998; 1400:29-43;PMID:9748489
46. Kõll P, Mändar R, Smidt I, Hütt P, Truusalu K, Mikelsaar RH, et al. Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probiotics. Curr Microbiol 2010; 61:560-6; PMID:20443005; http://dx.doi.org/10.1007/s00284-010-9653-y
47. Klein G, Hallmann C, Casas IA, Abad J, Louwers J, Reuter G. Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods. J Appl Microbiol 2000; 89:815-24; PMID:11119156;http://dx.doi.org/10.1046/j.1365-2672.2000.01187.x
48. Kumano M, Tamakoshi A, Yamane K. A 32 kb nucleotide sequence from the region of the lincomycinresistance gene (22°-25°) of the Bacillus subtilis chromosome and identification of the site of the lin-2 mutation. Microbiology 1997; 143:2775-82; PMID:9274031;http://dx.doi.org/10.1099/00221287-143-8-2775
49. Kim HJ, Kim Y, Lee MS, Lee HS. Gene lmrB of Corynebacterium glutamicum confers efflux-mediated resistance to lincomycin. Mol Cells 2001; 12:112-6;PMID:11561719
50. Vesterlund S, Vankerckhoven V, Saxelin M, Goossens H, Salminen S, Ouwehand AC. Safety assessment of Lactobacillus strains: presence of putative risk factors in faecal, blood and probiotic isolates. Int J Food Microbiol 2007; 116:325-31; PMID:17391794; http://dx.doi.org/10.1016/j.ijfoodmicro.2007.02.002
51. Husain S. Effect of ferric iron on siderophore production and pyrene degradation by Pseudomonas fluorescens 29L. Curr Microbiol 2008; 57:331-4;PMID:18626691; http://dx.doi.org/10.1007/s00284-008-9198-5
52. Elli M, Zink R, Rytz A, Reniero R, Morelli L. Iron requirement of Lactobacillus spp. in completely chemically defined growth media. J Appl Microbiol 2000; 88:695-703; PMID:10792529; http://dx.doi.org/10.1046/j.1365-2672.2000.01013.x
53. Maragkoudakis PA, Zoumpopoulou G, Miaris C, Kalantzopoulos G, Pot B, Tsakalidou E. Probiotic potential of Lactobacillus strains isolated from dairy products. Internation Dairy Journal 2006; 189-199.
54. Baumgartner A, Kueffer M, Simmen A, Grand M. Relatedness of Lactobacillus rhamnosus strains isolated from clinical specimens and such from food-stuffs, humans and technology. Lebensmittel-Wissenschaft und-Technologie 1998; 31:489-494; http://dx.doi.org/10.1006/fstl.1998.0395
55. Jönsson G, Midtvedt AC, Norman A, Midtvedt T. Intestinal microbial bile acid transformation in healthy infants. J Pediatr Gastroenterol Nutr 1995; 20:394-402; PMID:7636681; http://dx.doi.org/10.1097/00005176-199505000-00004
56. Kurdi PK, Kawanishi K, Mizutani K, Yokota A. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol 2006; 188: 1979-86; PMID:16484210; http://dx.doi.org/10.1128/JB.188.5.1979-1986.2006
57. Goldin BR, Gorbach SL. Probiotics for humans. In Probiotics in the Scientific Basis, ed. Fuller, R. Chapman & Hall 1992; 355-376. ISBN 0-412-40850-3.
58. Cukrowska B, Motyl I, Kozáková H, Schwarzer M, Górecki RK, Klewicka E, et al. Probiotic Lactobacillus strains: in vitro and in vivo studies. Folia Microbiol (Praha) 2009; 54:533-7; PMID:20140722; http://dx.doi.org/10.1007/s12223-009-0077-7
59. Delgado S, O'Sullivan E, Fitzgerald G, Mayo B. Subtractive Screening for Probiotic Properties of Lactobacillus Species from the Human Gastrointestinal Tract in the Search for New Probiotics. Food Microbiology and Safety 2007; 72:310-5.
60. McAuliffe O, Cano RJ, Klaenhammer TR. Genetic analysis of two bile salt hydrolase activities in Lactobacillus acidophilus NCFM. Appl Environ Microbiol 2005; 71:4925-9; PMID:16085898; http://dx.doi.org/10.1128/AEM.71.8.4925-4929.2005
61. Chateau N, Deschamps AM, Hadh-Sassi A. Heterogeneity of bile salts resistance in the Lactobacillus isolates from a probiotic consortium. Lett Appl Microbiol 1994; 18:42-4; http://dx.doi.org/10.1111/j.1472-765X.1994.tb00796.x
62. Gilliland SE, Staley TE, Bush LJ. Importance of bile tolerance of Lactobacillus acidophilus used as a dietary adjunct. J Dairy Sci 1984; 67:3045-51; PMID:6442304; http://dx.doi.org/10.3168/jds.S0022-0302(84)81670-7
63. du Toit M, Franz CM, Dicks LM, Schillinger U, Haberer P, Warlies B, et al. Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. Int J Food Microbiol 1998; 40:93-104; PMID:9600615; http://dx.doi.org/10.1016/S0168-1605(98)00024-5
64. Pfeiler EA, Klaenhammer TR. Role of transporter proteins in bile tolerance of Lactobacillus acidophilus. Appl Environ Microbiol 2009; 75:6013-6; PMID: 19633113; http://dx.doi.org/10.1128/AEM.00495-09
65. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004; 28:405-40; PMID:15374659; http://dx.doi.org/10.1016/j.femsre.2004.01.003
66. Martín R, Olivares M, Marín ML, Fernández L, Xaus J, Rodríguez JM. Probiotic potential of 3 Lactobacilli strains isolated from breast milk. J Hum Lact 2005; 21:8-17, quiz 18-21, 41; PMID:15681631; http://dx.doi.org/10.1177/0890334404272393
67. Fernández MF, Boris S, Barbés C. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 2003; 94:449-55; PMID:12588553; http://dx.doi.org/10.1046/j.1365-2672.2003.01850.x
68. Jacobsen CNV, Rosenfeldt Nielsen V, Hayford AE, Møller PL, Michaelsen KF, Paerregaard A, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999; 65:4949-56; PMID:10543808
69. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 2001; 73 (Suppl):386S-92S; PMID:11157346
70. Servin AL, Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 2003; 17:741-54; PMID:14507585; http://dx.doi.org/10.1016/S1521-6918(03)00052-0
71. Blum S, Reniero R, Schiffrin EJ, Crittenden R, Mattila- Sandholm T, Ouwehand AC, et al. Adhesion studies for probiotic: need for validation and refinement. Trends Food Sci Technol 1999; 10:405-10; http://dx.doi.org/10.1016/S0924-2244(00)00028-5
72. Lenaerts K, Bouwman FG, Lames WH, Renes J, Mariman EC. Comparative proteomics analysis of cell lines and scraping of the human intestinal ephitelium. BMC Genomics 2007; 8:1; PMID:17199895; http://dx.doi.org/10.1186/1471-2164-8-91
73. Spencer RJ, Chesson A. The effect of Lactobacillus spp. on the attachment of enterotoxigenic Escherichia coli to isolated porcine enterocytes. J Appl Bacteriol 1994; 77:215-20; PMID:7961193; http://dx.doi.org/10.1111/j.1365-2672.1994.tb03066.x
74. Horie M, Murakami T, Sato T, Tarusawa Y, Nakamura S, Toba T. Anaerobic induction of adherence to laminin in Lactobacillus gasseri strains by contact with solid surface. Curr Microbiol 2005; 51:275-82;PMID:16086101; http://dx.doi.org/10.1007/s00284-005-4572-z